SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AngioSoma, Inc. (SOAN) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 13/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SOAN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio264,565.58
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2011 |
$-12.02 |
$0.00 |
$-54.11K |
- |
| 2012 |
$-116.38 |
$0.00 |
$-1.09M |
- |
| 2013 |
$-11.99 |
$57.36K |
$-946.11K |
-1649.4% |
| 2014 |
$-7.50 |
$97.25K |
$-1.25M |
-1280.4% |
| 2015 |
$-0.66 |
$42.15K |
$-1.09M |
-2575.5% |
| 2016 |
$-0.13 |
$0.00 |
$-3.5M |
- |
| 2017 |
$-0.04 |
$0.00 |
$-1.68M |
- |
| 2018 |
$-0.01 |
$890.00 |
$-816.74K |
-91768.7% |
| 2019 |
$-0.01 |
$425.00 |
$-675.07K |
-158840.5% |
| 2020 |
$0.00 |
$77.00 |
$-541.73K |
-703546.8% |
